SCHEMBL2807815

SCHEMBL2807815

CC(=COc1ccc(-c2ccccc2)cc1)C(=O)Nc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.50
PTPN11 Q06124 1/20 0.50
DHODH Q02127 1/20 0.47
NAPRT Q6XQN6 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
KMT2A Q03164 4/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807812 1.00 PTPN1 (0.50) PTPN1PTPN11DHODHNAPRTHSD17B10
SCHEMBL2811479 0.91 NAPRT (0.48) NAPRTHSD17B10KMT2APOLBRAB9A
SCHEMBL2811474 0.91 NAPRT (0.48) NAPRTHSD17B10KMT2APOLBRAB9A
SCHEMBL2811497 0.88 KMT2A (0.47) NAPRTHSD17B10KMT2ARAB9AMEN1
SCHEMBL2810917 0.88 SMN1; SMN2 (0.55) KMT2ARAB9AALDH1A1MAPTCYP3A4
SCHEMBL2808701 0.88 HPGD (0.53) KMT2APOLBRAB9AMEN1ALDH1A1
SCHEMBL2810919 0.88 SMN1; SMN2 (0.55) KMT2ARAB9AALDH1A1MAPTCYP3A4
SCHEMBL2808697 0.88 HPGD (0.53) KMT2APOLBRAB9AMEN1ALDH1A1
SCHEMBL2811502 0.88 KMT2A (0.47) NAPRTHSD17B10KMT2ARAB9AMEN1
SCHEMBL2808882 0.87 MEN1 (0.46) NAPRTHSD17B10KMT2ARAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 PTPN1 4056/4885PTPN11 3565/4885DHODH 2526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.